D.E. Shaw & Co’s PharMerica Corporation PMC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-326,593
| Closed | -$9.57M | – | 3874 |
|
|
2017
Q3 | $9.57M | Sell |
326,593
-46,585
| -12% | -$1.3M | 0.01% | 975 |
|
|
2017
Q2 | $9.8M | Buy |
373,178
+34,364
| +10% | +$845K | 0.02% | 915 |
|
|
2017
Q1 | $7.93M | Buy |
338,814
+10,350
| +3% | +$255K | 0.01% | 1001 |
|
|
2016
Q4 | $8.26M | Buy |
328,464
+71,654
| +28% | +$1.81M | 0.01% | 1057 |
|
|
2016
Q3 | $7.21M | Sell |
256,810
-69,015
| -21% | -$1.77M | 0.01% | 1075 |
|
|
2016
Q2 | $8.04M | Sell |
325,825
-77,578
| -19% | -$1.92M | 0.01% | 1009 |
|
|
2016
Q1 | $8.92M | Sell |
403,403
-54,954
| -12% | -$1.46M | 0.02% | 930 |
|
|
2015
Q4 | $16M | Sell |
458,357
-44,491
| -9% | -$1.39M | 0.02% | 739 |
|
|
2015
Q3 | $14.3M | Sell |
502,848
-7,788
| -2% | -$262K | 0.02% | 763 |
|
|
2015
Q2 | $17M | Buy |
510,636
+92,669
| +22% | +$2.84M | 0.03% | 696 |
|
|
2015
Q1 | $11.8M | Sell |
417,967
-88,071
| -17% | -$2.19M | 0.02% | 875 |
|
|
2014
Q4 | $10.5M | Buy |
506,038
+52,725
| +12% | +$1.25M | 0.01% | 1080 |
|
|
2014
Q3 | $11.1M | Buy |
453,313
+33,558
| +8% | +$890K | 0.01% | 1021 |
|
|
2014
Q2 | $12M | Sell |
419,755
-65,030
| -13% | -$1.81M | 0.02% | 980 |
|
|
2014
Q1 | $13.6M | Sell |
484,785
-36
| -0% | -$884 | 0.02% | 866 |
|
|
2013
Q4 | $10.4M | Buy |
484,821
+24,497
| +5% | +$445K | 0.01% | 1114 |
|
|
2013
Q3 | $6.11M | Sell |
460,324
-131,982
| -22% | -$1.78M | 0.01% | 1412 |
|
|
2013
Q2 | $8.21M | Buy |
+592,306
| New | +$8.39M | 0.02% | 998 |
|
D.E. Shaw & Co's PMC Position: Q4 2017 in Review
D.E. Shaw & Co sold out of PharMerica Corporation (PMC) in Q4 2017, closing a stake of 326,593 shares — an estimated $9.57M sold.
D.E. Shaw & Co first reported a position in PMC in Q2 2013 and held it in 18 quarters. The position peaked at $17M in Q2 2015. 0 funds tracked by Wall St. Rank hold PMC as of Q4 2017.
- D.E. Shaw & Co reported no remaining PharMerica Corporation position as of Q4 2017 after selling out during the quarter.
- D.E. Shaw & Co sold 326,593 PharMerica Corporation shares in Q4 2017, an estimated $9.57M.
- D.E. Shaw & Co first reported a position in PharMerica Corporation in Q2 2013 and held it in 18 quarters.
- D.E. Shaw & Co's PharMerica Corporation position peaked at $17M in Q2 2015.
- 0 funds tracked by Wall St. Rank held PharMerica Corporation as of Q4 2017.
Based on D.E. Shaw & Co's 13F filing for Q4 2017, filed 14 Feb 2018.